Rating. The Company has no debt securities or preferred shares that are rated by any “nationally recognized statistical rating organization” (as that term is defined in Section 3(a)(62) of the Exchange Act).
Appears in 7 contracts
Samples: Underwriting Agreement (Profound Medical Corp.), Reunion Neuroscience (Reunion Neuroscience Inc.), Equity Distribution Agreement (Profound Medical Corp.)
Rating. The Company has no debt securities or preferred shares stock that are is rated by any “nationally recognized statistical rating organization” (as that term is defined by the Commission in Section 3(a)(62) of the Exchange 1934 Act).
Appears in 4 contracts
Samples: Underwriting Agreement (Karyopharm Therapeutics Inc.), Underwriting Agreement (Karyopharm Therapeutics Inc.), Karyopharm Therapeutics Inc.
Rating. The Company has no debt securities or preferred shares that are rated by any “nationally recognized statistical rating organization” (as that term is defined in Section 3(a)(62by the Commission for purposes of Rule 436(g)(2) of under the Exchange Securities Act).
Appears in 3 contracts
Samples: Sales Agreement (Trillium Therapeutics Inc.), Underwriting Agreement (Trillium Therapeutics Inc.), Underwriting Agreement (Trillium Therapeutics Inc.)
Rating. The Company has no debt securities or preferred shares that are rated by any “"nationally recognized statistical rating organization” " (as that term is defined in Section 3(a)(62by the Commission for purposes of Rule 436(g)(2) of under the Exchange Securities Act).
Appears in 3 contracts
Samples: Underwriting Agreement (Trillium Therapeutics Inc.), Underwriting Agreement (Trillium Therapeutics Inc.), Trillium Therapeutics Inc.
Rating. The Company has no debt securities or preferred shares stock that are rated by any “nationally recognized statistical rating organizationagency” (as that term is defined in Section 3(a)(62) of the Exchange 1934 Act).
Appears in 2 contracts
Samples: Underwriting Agreement (Centrexion Therapeutics Corp), Underwriting Agreement (Centrexion Therapeutics Corp)
Rating. The Company has no debt securities or preferred shares stock that are is rated by any “nationally recognized statistical rating organizationagency” (as that term is defined by the Commission as such term is defined in Section 3(a)(62) of the Exchange 1934 Act).
Appears in 1 contract
